Concepedia

Ferry Lalezari

FL

Statistics

Publications

24

Citations

4.1K

H-Index

21

Active since

2007

Affiliations

The Netherlands Cancer Institute(Current)

Oncode Institute

Radboud University Nijmegen

Nanostring Technologies (United States)

Erasmus MC

Ferry Lalezari is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2007–2023

24

Publications

24

Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non–Small Cell Lung Cancer

Willemijn S.M.E. Theelen, Heike Peulen, Ferry Lalezari et al. · JAMA Oncology · 2019 · 935 citations · Full text

Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

Leonie Voorwerk, Maarten Slagter, Hugo M. Horlings et al. · Nature Medicine · 2019 · 854 citations

, , +10

Predicting response to cancer immunotherapy using noninvasive radiomic biomarkers

Stefano Trebeschi, Silvia Girolama Drago, Nicolai J. Birkbak et al. · Annals of Oncology · 2019 · 533 citations · Full text

Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma

Maartje W. Rohaan, Troels Holz Borch, Joost H. van den Berg et al. · New England Journal of Medicine · 2022 · 474 citations · Full text

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma

Josine M.M.F. Quispel-Janssen, Vincent van der Noort, Jeltje F. de Vries et al. · Journal of Thoracic Oncology · 2018 · 244 citations · Full text

1–5 of 24